Black Diamond Therapeutics, Inc. Logo

Black Diamond Therapeutics, Inc.

Develops precision oncology therapies targeting families of oncogenic mutations.

BDTX | US

Overview

Corporate Details

ISIN(s):
US09203E1055
LEI:
Country:
United States of America
Address:
ONE MAIN STREET, 14TH FLOOR, 2142 CAMBRIDGE

Description

Black Diamond Therapeutics, Inc. is a clinical-stage precision oncology company developing MasterKey therapies. These therapies are designed to target families of oncogenic mutations in patients with genetically defined cancers. The company's approach aims to provide a single solution for multiple mutations, thereby expanding the addressable patient population. The therapies are engineered to overcome treatment resistance, minimize toxicities related to wild-type proteins, and be brain-penetrant to treat central nervous system diseases. Primary areas of focus include non-small cell lung cancer (NSCLC) and glioblastoma (GBM).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Black Diamond Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Black Diamond Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Black Diamond Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BIO-FD&C CO.,LTD. Logo
Develops active ingredients for cosmetics and pharma using a plant cell platform technology.
South Korea
251120
Biofrontera AG Logo
Biopharmaceutical firm specializing in photodynamic therapy for skin conditions.
Germany
B8F
Biofrontera Inc. Logo
A biopharmaceutical company commercializing products for dermatological conditions.
United States of America
BFRI
BioGaia Logo
A healthcare and biotechnology company developing clinically proven probiotic products.
Sweden
BIOG
BIOGEN INC. Logo
Biotechnology company developing therapies for neurological and neurodegenerative diseases.
United States of America
BIIB
Bio Green Med Solution, Inc. Logo
A diversified company in the biopharmaceutical and fire safety sectors.
United States of America
BGMS
BIOHARVEST SCIENCES INC. Logo
A biotech firm using a platform to grow plant cells for health and wellness products.
United States of America
BHST
Biohaven Ltd. Logo
Develops therapies for neuroscience, immunology, and oncology for unmet medical needs.
United States of America
BHVN
BioInvent International Logo
Develops novel, first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden
BINV
BIOLIFE SOLUTIONS INC Logo
Manufactures biopreservation media and tools for cell and gene therapy markets.
United States of America
BLFS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.